Nutrition Support
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
11 treatments under study, led by Oliclinomel N4
Research Leaders
6 sponsors active, led by Hospital General Universitario Reina Sofía de Murcia
Related Conditions
Often studied with 14 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition
Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk
Postoperative Diet With Hyperproteic Supplement Versus a Supplement With Imunonutrients, in Colorectal Cancer Surgery
Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting
Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation
Research Network
Common Treatments
- Oliclinomel N41
- 36 Hour Fasting1
- High Leucine Content Drink1
- Controlcarbohydrate1
- Continuous Enteral Nutrition Infusion1
Active Sponsors
- Hospital General Universitario Reina Sofía de Murcia1
- Hospital Universitario San Ignacio1
- Baxter Healthcare Corporation1
- Third Affiliated Hospital, Sun Yat-Sen University1
- Children's Hospital of Fudan University1
Top Investigators
Haikou, China
Changsha, China
Jiangsu Province, China
Hangzhou, China
Shanghai, China
Related Conditions
- Colorectal Cancer1
- Enteral Feeding Intolerance1
- Surgerycomplications1
- Biliary Atresia1
- Malnutrition1